— Know what they know.
Not Investment Advice
Also trades as: KNE.V (TSXV) · $vol 0M

KNBIF OTC

Kane Biotech Inc.
1W: +3.2% 1M: -0.2% 3M: -5.3% YTD: -30.6% 1Y: -43.7% 3Y: -75.4% 5Y: -89.8%
$0.02
-0.00 (-2.79%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $3.8M mcap · 105M float · 0.102% daily turnover · Short 73% of daily vol

Balance Sheet Trends

Total Assets
$2M -56.1% ▼
5Y CAGR: -2.0%
Total Liabilities
$4M -70.7% ▼
5Y CAGR: +16.5%
Shareholders Equity
-$2M +84.6% ▲
Cash & Investments
$359K -52.1% ▼
5Y CAGR: -15.5%
Total Debt
$2M -76.5% ▼
5Y CAGR: +66.5%
Net Debt
$2M -78.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$1M$1M$1M$749K$359K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1M$1M$1M$749K$359K
Net Receivables$1M$1M$1M$4K$88K
Inventory$472K$519K$763K$250K$376K
Other Current Assets$143K$137K$171K$3M$206K
Total Current Assets$3M$3M$3M$4M$1M
Property, Plant & Equip.$163K$1M$1M$1M$929K
Goodwill & Intangibles$777K$829K$826K$733K$536K
Long-Term Investments$1M$989K$444K$0$0
Other Non-Current Assets$1M$989K$444K$159K$0
Total Non-Current Assets$2M$3M$3M$2M$1M
Total Assets$5M$6M$6M$6M$2M
— Liabilities —
Accounts Payable$662K$626K$603K$437K$1M
Short-Term Debt$2M$2M$4M$7M$344K
Deferred Revenue$67K$143K$208K$0$0
Other Current Liabilities$635K$1M$1M$3M$120K
Total Current Liabilities$3M$5M$6M$11M$2M
Long-Term Debt$657K$1M$2M$1M$958K
Other Non-Current Liab.$347K$777K$837K$829K$0
Total Non-Current Liabilities$1M$3M$3M$3M$2M
Total Liabilities$4M$8M$10M$14M$4M
— Equity —
Common Stock$21M$22M$23M$24M$24M
Retained Earnings-$29M-$33M-$37M-$42M-$34M
Accumulated OCI$2M$2M$0$141K$0
Total Stockholders Equity-$1M-$4M-$7M-$11M-$2M
Total Liabilities & Equity$5M$6M$6M$6M$2M
— Key Metrics —
Total Debt$2M$5M$7M$9M$2M
Net Debt$1M$4M$6M$9M$2M
Total Investments$1M$989K$444K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms